Showing results (121-130 of 289) with videos related to
Sort By:
Pageof 29
Eclinicalmedicine|September 18, 2024
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort studyMary Eapen, Joseph H Antin, Jakub Tolar, et al.Blood|February 24, 2007
Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTJeffery S Miller, Sarah Cooley, Peter Parham, et al.Blood|September 10, 2010
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantationJohn R Wingard, Shelly L Carter, Thomas J Walsh, et al.Stem Cells (Dayton, Ohio)|May 7, 2009
Stem cells, multiorgan failure in radiation emergency medical preparedness: a U.S./European Consultation WorkshopTheodor M Fliedner, Nelson J Chao, Judith L Bader, et al.American Journal of Hematology|October 17, 2022
Health-related quality of life in reduced-intensity hematopoietic cell transplantation based on donor availability in patients aged 50-75 with advanced myelodysplastic syndrome: BMT CTN 1102Rachel Cusatis, Michael J Martens, Ryotaro Nakamura, et al.Transplantation and Cellular Therapy|April 23, 2023
Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101Najla El Jurdi, Michael J Martens, Claudio G Brunstein, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Mapping MHC-resident transplantation determinantsMari Malkki, Ted A Gooley, Mary M Horowitz, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 22, 2018
Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell TransplantChristopher Strouse, Ying Zhang, Mei-Jie Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2012
Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantationMarcelo C Pasquini, Steven Devine, Adam Mendizabal, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 29, 2013
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myelomaRobert Frank Cornell, Parameswaran Hari, Mei-Jie Zhang, et al.Pageof 29